[go: up one dir, main page]

ATE353887T1 - METHOD FOR PRODUCING OPTICALLY PURE OR OPTICALLY ENRICHED SULFOXIDE COMPOUNDS INCLUDING AMORPHENE ESOMEPRAZOLE AND SALTS THEREOF - Google Patents

METHOD FOR PRODUCING OPTICALLY PURE OR OPTICALLY ENRICHED SULFOXIDE COMPOUNDS INCLUDING AMORPHENE ESOMEPRAZOLE AND SALTS THEREOF

Info

Publication number
ATE353887T1
ATE353887T1 AT03762106T AT03762106T ATE353887T1 AT E353887 T1 ATE353887 T1 AT E353887T1 AT 03762106 T AT03762106 T AT 03762106T AT 03762106 T AT03762106 T AT 03762106T AT E353887 T1 ATE353887 T1 AT E353887T1
Authority
AT
Austria
Prior art keywords
esomeprazole
amorphene
salts
optically
compounds including
Prior art date
Application number
AT03762106T
Other languages
German (de)
Inventor
Manne Satyanarayana Reddy
Muppa Kishore Kumar
Kikkuru Srirami Reddy
Koilkonda Purandhar
Keshaboina Sreenath
Original Assignee
Reddys Lab Ltd Dr
Reddys Lab Inc Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr filed Critical Reddys Lab Ltd Dr
Application granted granted Critical
Publication of ATE353887T1 publication Critical patent/ATE353887T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process of preparation of optically pure or optically enriched isomers of omeprazole and structurally related sulfoxides is provided. Also provided ar e an amorphous form of esomeprazole, as well a pharmaceutical composition containing it and a method of using it for treatment of gastric disorders.</ SDOAB>
AT03762106T 2002-06-27 2003-06-27 METHOD FOR PRODUCING OPTICALLY PURE OR OPTICALLY ENRICHED SULFOXIDE COMPOUNDS INCLUDING AMORPHENE ESOMEPRAZOLE AND SALTS THEREOF ATE353887T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN489MA2002 2002-06-27
IN493MA2002 2002-06-28

Publications (1)

Publication Number Publication Date
ATE353887T1 true ATE353887T1 (en) 2007-03-15

Family

ID=34276871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762106T ATE353887T1 (en) 2002-06-27 2003-06-27 METHOD FOR PRODUCING OPTICALLY PURE OR OPTICALLY ENRICHED SULFOXIDE COMPOUNDS INCLUDING AMORPHENE ESOMEPRAZOLE AND SALTS THEREOF

Country Status (5)

Country Link
CN (1) CN100378093C (en)
AT (1) ATE353887T1 (en)
AU (1) AU2003247729B2 (en)
CA (1) CA2491118A1 (en)
DE (1) DE60311809T2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143722A1 (en) * 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
CN103145694B (en) * 2011-12-06 2016-01-20 重庆煜澍丰医药有限公司 Crystal R of Esomeprazole sodium salt and its production and use
CN102993184A (en) * 2013-01-08 2013-03-27 湖南方盛制药股份有限公司 Esomeprazole and preparation method of magnesium trihydrate of esomeprazole
CN103664887B (en) * 2013-12-18 2015-09-16 成都医路康医学技术服务有限公司 The preparation method of Esomeprazole sodium
CN104530003A (en) * 2014-06-10 2015-04-22 广东东阳光药业有限公司 Preparation method of salt of pyridylmethylsulfinyl-1H-benzimidazole compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510666C2 (en) * 1996-12-20 1999-06-14 Astra Ab New Crystal Modifications
SE510650C2 (en) * 1997-05-30 1999-06-14 Astra Ab New association
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Also Published As

Publication number Publication date
DE60311809D1 (en) 2007-03-29
AU2003247729B2 (en) 2009-10-08
AU2003247729A1 (en) 2004-01-19
CN100378093C (en) 2008-04-02
CN1665805A (en) 2005-09-07
CA2491118A1 (en) 2004-01-08
DE60311809T2 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
WO2004002982A3 (en) A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
ATE268179T1 (en) USE OF SUBSTITUTED IMIDAZO (1,2-A)PYRIDINE, PYRIMIDINE AND PYRAZINE-3-YL-AMINE DERIVATIVES FOR THE PRODUCTION OF NOS INHIBITION MEDICATIONS
BR0205722A (en) Prolonged release formulation and method for treating a patient suffering from pain
DE602004020263D1 (en) AMINO-SUBSTITUTED DIARYLÄA, DREPTYCLEPTEN ANALOGUE AS MUSCARINAL AGONISTS AND METHOD FOR THE TREATMENT OF NEUROPSYCHIATRICAL DISEASES
MXPA03011484A (en) Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.
DE502004005033D1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE TREATMENT OF DEPRESSIONS
DE60216830D1 (en) Pharmaceutical compositions for the treatment of disorders of the CNS or other diseases
BR0309345A (en) Pharmaceutically acceptable compound or salts thereof, pharmaceutical composition, use of a compound, and methods of treating or prophylaxis of human diseases or conditions, psychotic disorders or disorders of intellectual damage, and jetlag, smoking cessation, addiction of nicotine, cravings, pain and ulcerative colitis
DE602004029580D1 (en) SUBSTITUTED INDOIND DERIVATIVES FOR A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES
EA200601584A1 (en) GLUCOPIRANOZE-SUBSTITUTED BENZENE DERIVATIVES CONTAINING THESE COMPOUNDS MEDICINES, THEIR APPLICATION AND METHOD FOR THEIR PRODUCTION
UA83867C2 (en) Amide derivatives, process for the preparation thereof (variants), pharmaceutical composition, methods of treatment based thereon and use thereof
EA200401365A1 (en) METHODS OF TREATMENT OF ILEUS
YU35503A (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
BR0309185A (en) Beta-mimetic drug and a new anticholinergic
BR0316723A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2003087049A3 (en) Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
DE602004002394D1 (en) (3-ä3 - &#39;(2,4-BIS-TRIFLUOROMETHYL-BENZYL) - (5-ETHYL-PYRIMIDIN-2-YL) -AMINOÜ-PROPOXYU-PHENYL) ACETIC ACID AND RELATED COMPOUNDS AS MODULATORS OF PPARS AND METHOD FOR THE TREATMENT OF METABOLIC DISORDERS
EA200602016A1 (en) POWDER COMPOSITIONS FOR INHALATION CONTAINING ENANTIOMERNA CLEAN AGENTISTS
ATE353887T1 (en) METHOD FOR PRODUCING OPTICALLY PURE OR OPTICALLY ENRICHED SULFOXIDE COMPOUNDS INCLUDING AMORPHENE ESOMEPRAZOLE AND SALTS THEREOF
ATE252383T1 (en) USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AND/OR ITS PHYSIOLOGICALLY TOLERABLE SALTS FOR THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF CANCER DISEASES
BRPI0417117A (en) crystallized temozolomide, crystallized temozolomide preparation process, pharmaceutical composition, method of producing medicament containing temozolomide and method of treating a medical condition for which thermozolomide is beneficial
ATE334980T1 (en) METHOD FOR PRODUCING 2-METHYL PIPERAZINE DERIVATIVES.
ATE497958T1 (en) METHOD FOR PRODUCING SYNTHETIC DERIVATIVES OF DIBENZYLBUTYROLACTONE LIGNANS WITH ANTICHAGAS PROPERTIES
DE60335892D1 (en) PHARMACEUTICAL COMPOSITION RELATING TO THE PRODUCTION OF A MEDICAMENT FOR TREATMENT AND / OR PREVENTATION AND / OR OBSERVANCE OF FAT CONNECTION
DE60142304D1 (en) SUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF MULTIPLE MEDICAMENT RESISTANCE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties